Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$9.18 - $11.53 $733,803 - $921,650
79,935 New
79,935 $896,000
Q3 2022

Nov 14, 2022

BUY
$6.46 - $12.11 $59,192 - $110,963
9,163 Added 14.24%
73,520 $814,000
Q2 2022

Aug 15, 2022

BUY
$6.2 - $15.5 $19,027 - $47,569
3,069 Added 5.01%
64,357 $544,000
Q1 2022

May 11, 2022

BUY
$11.55 - $20.06 $22,499 - $39,076
1,948 Added 3.28%
61,288 $834,000
Q4 2021

Feb 11, 2022

BUY
$17.83 - $33.15 $21,360 - $39,713
1,198 Added 2.06%
59,340 $1.17 Million
Q3 2021

Nov 12, 2021

BUY
$30.69 - $36.83 $224,742 - $269,706
7,323 Added 14.41%
58,142 $1.87 Million
Q2 2021

Aug 11, 2021

BUY
$32.66 - $39.87 $313,438 - $382,632
9,597 Added 23.28%
50,819 $1.72 Million
Q1 2021

May 13, 2021

SELL
$33.86 - $48.68 $82,821 - $119,071
-2,446 Reduced 5.6%
41,222 $1.55 Million
Q4 2020

Feb 09, 2021

SELL
$33.22 - $50.26 $8,770 - $13,268
-264 Reduced 0.6%
43,668 $1.45 Million
Q3 2020

Nov 12, 2020

SELL
$29.24 - $40.19 $5,350 - $7,354
-183 Reduced 0.41%
43,932 $1.61 Million
Q2 2020

Aug 12, 2020

BUY
$25.06 - $54.6 $147,402 - $321,157
5,882 Added 15.38%
44,115 $1.45 Million
Q1 2020

May 06, 2020

BUY
$24.65 - $42.83 $331,271 - $575,592
13,439 Added 54.2%
38,233 $987,000
Q4 2019

Feb 14, 2020

BUY
$18.59 - $37.67 $460,920 - $933,989
24,794 New
24,794 $772,000

Others Institutions Holding PHAT

About Phathom Pharmaceuticals, Inc.


  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $272M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.